Source: PR Newswire

Press Release: PTC : PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2025...

Read full article »

PTC's Competitors | PTC's News | PTC's Financials

Followers on Owler

274

Annual Revenue

$500M-1.0B

Employees

500-1.0K

CEO

Matthew Klein

CEO Approval Rating

83/100

PTC is a New Jersey-based pharmaceutical company that discovers and develops novel therapeutics to treat oncology, neurology, and metabolic disorders.